access your medical records
Home > Research at Avera > Clinical Trials at Avera > Clinical Trials Search Results
This study is designed to evaluate the safety and efficacy of dipraglurant in PD patients with dyskinesia for 12 weeks.
Master protocol designed to evaluate multiple investigational agents for the treatment of moderately or severely ill patients infected with severe acute respiratory syndrome coronavirus 2.
The study investigators are interested in learning more about how drugs act in the bodies of children and young adults in hopes to find the most safe and effective dose for children.
Identifying naturally evolving human antibodies to test potential efficacy at neutralizing SARS – COV-2
© 2022 Avera Health, Sioux Falls, SD. All Rights Reserved.